Jbm (Healthcare) Ltd
HKEX:2161

Watchlist Manager
Jbm (Healthcare) Ltd Logo
Jbm (Healthcare) Ltd
HKEX:2161
Watchlist
Price: 2.72 HKD -2.16% Market Closed
Market Cap: 2.2B HKD

Jbm (Healthcare) Ltd
Operating Income

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Jbm (Healthcare) Ltd
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Jbm (Healthcare) Ltd
HKEX:2161
Operating Income
HK$234.4m
CAGR 3-Years
82%
CAGR 5-Years
35%
CAGR 10-Years
N/A
G
Grand Pharmaceutical Group Ltd
HKEX:512
Operating Income
HK$2B
CAGR 3-Years
-9%
CAGR 5-Years
6%
CAGR 10-Years
19%
U
United Laboratories International Holdings Ltd
HKEX:3933
Operating Income
ÂĄ3.6B
CAGR 3-Years
39%
CAGR 5-Years
24%
CAGR 10-Years
16%
Sino Biopharmaceutical Ltd
HKEX:1177
Operating Income
ÂĄ5.3B
CAGR 3-Years
-12%
CAGR 5-Years
0%
CAGR 10-Years
10%
C
China Resources Pharmaceutical Group Ltd
HKEX:3320
Operating Income
HK$12.8B
CAGR 3-Years
5%
CAGR 5-Years
7%
CAGR 10-Years
N/A
H
HUTCHMED (China) Ltd
HKEX:13
Operating Income
-$19.7m
CAGR 3-Years
58%
CAGR 5-Years
34%
CAGR 10-Years
3%
No Stocks Found

Jbm (Healthcare) Ltd
Glance View

Market Cap
2.2B HKD
Industry
Pharmaceuticals

JBM (Healthcare) Ltd. functions as an investment holding company. The company employs 274 full-time employees The company went IPO on 2021-02-05. The firm operates its business through three segments. The Proprietary Chinese Medicines segment mainly distributes over the counter (OTC) proprietary Chinese medicines and concentrated Chinese medicine granule (CCMG) products. The Consumer Healthcare Products segment primarily distributes proprietary medicines in the form of OTC. The Health and Wellness Products segment sales and distributes health and wellness products. The firm operates business in domestic and overseas markets such as Southeast Asia, Europe, and North America.

Intrinsic Value
4.35 HKD
Undervaluation 37%
Intrinsic Value
Price

See Also

What is Jbm (Healthcare) Ltd's Operating Income?
Operating Income
234.4m HKD

Based on the financial report for Mar 31, 2025, Jbm (Healthcare) Ltd's Operating Income amounts to 234.4m HKD.

What is Jbm (Healthcare) Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
35%

Over the last year, the Operating Income growth was 44%. The average annual Operating Income growth rates for Jbm (Healthcare) Ltd have been 82% over the past three years , 35% over the past five years .

Back to Top